Skechers U S A Inc. (SKX) Jumps 7.51% on February 12

Equities Staff |

Skechers U S A Inc. (SKX) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 7.51% to $30.36, representing a gain of $2.12 per share. Some 4.01 million shares traded hands on 24,245 trades, compared with an average daily volume of 4.09 million shares out of a total float of 156.25 million. The stock opened at $28.68 and traded with an intraday range of $30.37 to $27.78.

After today's gains, Skechers U S A Inc. reached a market cap of $4.74 billion. Skechers U S A Inc. has had a trading range between $54.53 and $21.17 over the last year, and it had a 50-day SMA of $29.00 and a 200-day SMA of $36.81.

The stock has a P/E Ratio of 18.8.

Skechers USA Inc designs and markets Skechers-branded lifestyle footwear for men, women and children, and performance footwear for men and women under the Skechers GO brand name.

Skechers U S A Inc. is based out of Manhattan Beach, CA and has some 7,772 employees. Its CEO is Robert Greenberg.

For a complete fundamental analysis analysis of Skechers U S A Inc., check out’s Stock Valuation Analysis report for SKX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…